Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Litwin

Showing results (401-410 of 629) with videos related to

Pageof 63
Sort By:
The American Journal of Managed Care|August 30, 2021
Modeling financial outcomes and quantifying risk in episode-based payment modelsDavid C Johnson, Fernanda Bravo, Eric Kwok, et al.
Toxicon : Official Journal of the International Society on Toxinology|March 1, 2000
A comparison of different methods to assess the hemorrhagic activity of Bothrops venomsA R de Roodt, J A Dolab, J C Dokmetjian, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1993
Preservation of immune effector cell function following administration of a dose-intense 5-fluorouracil-chemotherapy regimenL M Weiner, G R Hudes, J Kitson, et al.
The Journal of Urology|February 22, 2008
The influence of cardiovascular disease on health related quality of life in men with prostate cancer: a 4-year followup studyLonneke V van de Poll-Franse, Lorna Kwan, Robert E Reiter, et al.
Cancer|March 14, 2007
Assessment of prognosis with the total illness burden index for prostate cancer: aiding clinicians in treatment choiceMark S Litwin, Sheldon Greenfield, Eric P Elkin, et al.
The American Surgeon|July 1, 1995
Reconstruction with myocutaneous flaps following resection of locally recurrent rectal cancerK A Yeh, J P Hoffman, J E Kusiak, et al.
Cancer|November 20, 2009
Urinary diversion and morbidity after radical cystectomy for bladder cancerJohn L Gore, Hua-Yin Yu, Claude Setodji, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1997
A solution to the rheumatoid factor paradox: pathologic rheumatoid factors can be tolerized by competition with natural rheumatoid factorsJ J Stewart, H Agosto, S Litwin, et al.
Clinical & Experimental Optometry|March 20, 2008
Glare and halo with refractive correctionRichard J Allen, George M Saleh, Andre S Litwin, et al.
Cancer|May 15, 1994
Is frozen section analysis of reexcision lumpectomy margins worthwhile? Margin analysis in breast reexcisionsE R Sauter, J P Hoffman, F D Ottery, et al.
Pageof 63

Showing results (401-410 of 629) with videos related to

Sort By:
Pageof 63
The American Journal of Managed Care|August 30, 2021
Modeling financial outcomes and quantifying risk in episode-based payment modelsDavid C Johnson, Fernanda Bravo, Eric Kwok, et al.
Toxicon : Official Journal of the International Society on Toxinology|March 1, 2000
A comparison of different methods to assess the hemorrhagic activity of Bothrops venomsA R de Roodt, J A Dolab, J C Dokmetjian, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1993
Preservation of immune effector cell function following administration of a dose-intense 5-fluorouracil-chemotherapy regimenL M Weiner, G R Hudes, J Kitson, et al.
The Journal of Urology|February 22, 2008
The influence of cardiovascular disease on health related quality of life in men with prostate cancer: a 4-year followup studyLonneke V van de Poll-Franse, Lorna Kwan, Robert E Reiter, et al.
Cancer|March 14, 2007
Assessment of prognosis with the total illness burden index for prostate cancer: aiding clinicians in treatment choiceMark S Litwin, Sheldon Greenfield, Eric P Elkin, et al.
The American Surgeon|July 1, 1995
Reconstruction with myocutaneous flaps following resection of locally recurrent rectal cancerK A Yeh, J P Hoffman, J E Kusiak, et al.
Cancer|November 20, 2009
Urinary diversion and morbidity after radical cystectomy for bladder cancerJohn L Gore, Hua-Yin Yu, Claude Setodji, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1997
A solution to the rheumatoid factor paradox: pathologic rheumatoid factors can be tolerized by competition with natural rheumatoid factorsJ J Stewart, H Agosto, S Litwin, et al.
Clinical & Experimental Optometry|March 20, 2008
Glare and halo with refractive correctionRichard J Allen, George M Saleh, Andre S Litwin, et al.
Cancer|May 15, 1994
Is frozen section analysis of reexcision lumpectomy margins worthwhile? Margin analysis in breast reexcisionsE R Sauter, J P Hoffman, F D Ottery, et al.
Pageof 63